Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Overgaard

Showing results (71-80 of 389) with videos related to

Pageof 39
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 12, 2007
Tumor progression in waiting time for radiotherapy in head and neck cancerAnni Ravnsbaek Jensen, Hanne Marie Nellemann, Jens Overgaard
Acta Oncologica (Stockholm, Sweden)|May 15, 2007
Late neurological complications after irradiation of malignant tumors of the testisMarianne M Knap, Søren M Bentzen, Jens Overgaard
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 8, 2010
High-resolution melting analysis for mutation screening of RGSL1, RGS16, and RGS8 in breast cancerEmilia Wiechec, Carsten Wiuf, Jens Overgaard, et al.
Acta Oncologica (Stockholm, Sweden)|September 20, 2006
Radiation administered as a large single dose or in a fractionated schedule: Role of the tumour vasculature as a target for influencing responseMichael R Horsman, Thomas Nielsen, Leif Østergaard, et al.
Seminars in Radiation Oncology|March 6, 2012
Hypoxia gene expression signatures as prognostic and predictive markers in head and neck radiotherapyKasper Toustrup, Brita S Sørensen, Jan Alsner, et al.
Acta Oncologica (Stockholm, Sweden)|September 29, 2021
Hypoxic gene expression is a prognostic factor for disease free survival in a cohort of locally advanced squamous cell cancer of the uterine cervixJan Alsner, Jens Overgaard, Trine Tramm, et al.
Lung Cancer (Amsterdam, Netherlands)|January 9, 2007
Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: relation to prognosis and angiogenesisBirgitte Vrou Offersen, Per Pfeiffer, Peter Andreasen, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|July 13, 2013
Optimal reference genes for normalization of qRT-PCR data from archival formalin-fixed, paraffin-embedded breast tumors controlling for tumor cell content and decay of mRNATrine Tramm, Brita S Sørensen, Jens Overgaard, et al.
Acta Oncologica (Stockholm, Sweden)|December 17, 2013
Compliance and toxicity of the hypoxic radiosensitizer nimorazole in the treatment of patients with head and neck squamous cell carcinoma (HNSCC)Mohamed A Hassan Metwally, Katrine Diemer Frederiksen, Jens Overgaard
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 10, 2014
Risk of second primary lung cancer in women after radiotherapy for breast cancerTrine Grantzau, Mette Skovhus Thomsen, Michael Væth, et al.
Pageof 39

Showing results (71-80 of 389) with videos related to

Sort By:
Pageof 39
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 12, 2007
Tumor progression in waiting time for radiotherapy in head and neck cancerAnni Ravnsbaek Jensen, Hanne Marie Nellemann, Jens Overgaard
Acta Oncologica (Stockholm, Sweden)|May 15, 2007
Late neurological complications after irradiation of malignant tumors of the testisMarianne M Knap, Søren M Bentzen, Jens Overgaard
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 8, 2010
High-resolution melting analysis for mutation screening of RGSL1, RGS16, and RGS8 in breast cancerEmilia Wiechec, Carsten Wiuf, Jens Overgaard, et al.
Acta Oncologica (Stockholm, Sweden)|September 20, 2006
Radiation administered as a large single dose or in a fractionated schedule: Role of the tumour vasculature as a target for influencing responseMichael R Horsman, Thomas Nielsen, Leif Østergaard, et al.
Seminars in Radiation Oncology|March 6, 2012
Hypoxia gene expression signatures as prognostic and predictive markers in head and neck radiotherapyKasper Toustrup, Brita S Sørensen, Jan Alsner, et al.
Acta Oncologica (Stockholm, Sweden)|September 29, 2021
Hypoxic gene expression is a prognostic factor for disease free survival in a cohort of locally advanced squamous cell cancer of the uterine cervixJan Alsner, Jens Overgaard, Trine Tramm, et al.
Lung Cancer (Amsterdam, Netherlands)|January 9, 2007
Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: relation to prognosis and angiogenesisBirgitte Vrou Offersen, Per Pfeiffer, Peter Andreasen, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|July 13, 2013
Optimal reference genes for normalization of qRT-PCR data from archival formalin-fixed, paraffin-embedded breast tumors controlling for tumor cell content and decay of mRNATrine Tramm, Brita S Sørensen, Jens Overgaard, et al.
Acta Oncologica (Stockholm, Sweden)|December 17, 2013
Compliance and toxicity of the hypoxic radiosensitizer nimorazole in the treatment of patients with head and neck squamous cell carcinoma (HNSCC)Mohamed A Hassan Metwally, Katrine Diemer Frederiksen, Jens Overgaard
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 10, 2014
Risk of second primary lung cancer in women after radiotherapy for breast cancerTrine Grantzau, Mette Skovhus Thomsen, Michael Væth, et al.
Pageof 39